Antigen phenotype and cytotoxic activity of natural killer cells in hemodialysis patients

被引:17
作者
Gascon, A
Orfao, A
Lerma, JL
Ciudad, J
Lopez, A
Hernandez, MD
Tabernero, JM
机构
[1] HOSP UNIV SALAMANCA,SERV NEFROL,E-37007 SALAMANCA,SPAIN
[2] HOSP UNIV SALAMANCA,SERV FLOW CYTOMETRY,E-37007 SALAMANCA,SPAIN
关键词
natural killer cells; antigen phenotype natural killer cells; cytotoxic activity natural killer cells; hemodialysis; hemodialysis membranes;
D O I
10.1016/S0272-6386(96)90360-1
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The antigen phenotype and cytotoxic activity of peripheral blood natural killer (NK) cells have been studied in 35 patients on hemodialysis, evaluating the influence exerted by different types of dialysis membranes and diverse clinical and biologic features of end-stage renal disease. Two-color immunofluorescent analyses with different monoclonal antibodies and flow cytometry were performed to identify the NK cells. Functional cytotoxic assays were simultaneously performed in the same patients. The results show that hemodialysis elicits higher proportions of CD3-/CD56+ and CD3-/CD16+ NK cells and a decrease in their cytotoxic activity compared with the control group. This alteration is related to the use of cuprophan membranes; biocompatible membranes would not significantly affect NK cells. The cuprophan membranes were also found to induce a higher degree of NK cell activation, measured as the number of CD16+/HLA-DR+ cells. Age appeared to be associated with NK cell function. Regarding age, in patients older than 65 years the change from cuprophan to biocompatible membranes was associated with a recovery in NK cytolytic activity to normal levels. In summary, hemodialysis with cuprophan membranes induces an increased proportion of both NK cells and activated NK cells associated with decreased NK cytolytic activity. (C) 1996 by the National Kidney Foundation, Inc.
引用
收藏
页码:373 / 379
页数:7
相关论文
共 35 条
[1]   DEPRESSED NATURAL-KILLER CELL-ACTIVITY IN UREMIA - EVIDENCE FOR IMMUNOSUPPRESSIVE FACTOR IN UREMIC SERA [J].
ASAKA, M ;
IIDA, H ;
IZUMINO, K ;
SASAYAMA, S .
NEPHRON, 1988, 49 (04) :291-295
[2]  
Baj Zbigbniew, 1992, Archivum Immunologiae et Therapiae Experimentalis, V40, P201
[3]   INVIVO T-CELL PREACTIVATION IN CHRONIC UREMIC HEMODIALYZED AND NON-HEMODIALYZED PATIENTS [J].
BEAURAIN, G ;
NARET, C ;
MARCON, L ;
GRATEAU, G ;
DRUEKE, T ;
URENA, P ;
NELSON, DL ;
BACH, JF ;
CHATENOUD, L .
KIDNEY INTERNATIONAL, 1989, 36 (04) :636-644
[4]   ANALYSIS OF IMMUNE STATUS OF HEMODIALYZED ADULTS - ASSOCIATION WITH PRIOR TRANSFUSIONS [J].
BENDER, BS ;
CURTIS, JL ;
NAGEL, JE ;
CHREST, FJ ;
KRAUS, ES ;
BRIEFEL, GR ;
ADLER, WH .
KIDNEY INTERNATIONAL, 1984, 26 (04) :436-443
[5]   NEGATIVE EFFECT OF UREMIA AND CUPROPHANE HEMODIALYSIS ON NATURAL-KILLER-CELLS [J].
CALA, S ;
MAZURAN, R ;
KORDIC, D .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1990, 5 (06) :437-440
[6]  
CHARPENTIER B, 1983, CLIN NEPHROL, V19, P288
[7]  
CHATENOUD L, 1994, KIDNEY INT, V45, pS92
[8]   PRESENCE OF PREACTIVATED T-CELLS IN HEMODIALYZED PATIENTS - THEIR POSSIBLE ROLE IN ALTERED IMMUNITY [J].
CHATENOUD, L ;
DUGAS, B ;
BEAURAIN, G ;
TOUAM, M ;
DRUEKE, T ;
VASQUEZ, A ;
GALANAUD, P ;
BACH, JF ;
DELFRAISSY, JF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (19) :7457-7461
[9]  
Chatenoud L, 1990, Adv Nephrol Necker Hosp, V19, P259
[10]   HEMODIALYSIS LEUKOPENIA - PULMONARY VASCULAR LEUKOSTASIS RESULTING FROM COMPLEMENT ACTIVATION BY DIALYZER CELLOPHANE MEMBRANES [J].
CRADDOCK, PR ;
FEHR, J ;
DALMASSO, AP ;
BRIGHAM, KL ;
JACOB, HS .
JOURNAL OF CLINICAL INVESTIGATION, 1977, 59 (05) :879-888